Saved report copy
Recorded
Elevance raises profit guidance as medical costs ease
Elevance Health raised its 2026 adjusted earnings guidance by $2 per share after third-quarter medical spending came in below Wall Street expectations. The company also expects adjusted earnings to rise at least 12% in 2027 from a new baseline of $26.75 per share, above the average analyst estimate, as lower medical costs, a better Affordable Care Act outlook and gains in private holdings supported its outlook. Shares rose 1.7% in early New York trading Wednesday and had gained more than 25% this year through Tuesday, though Medicaid funding cuts remain a risk.